Cargando…

Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor‐23

Myocardial infarction (MI) is a major cause of death worldwide. Epidemiological studies have linked vitamin D deficiency to MI incidence. Because fibroblast growth factor‐23 (FGF23) is a master regulator of vitamin D hormone production and has been shown to be associated with cardiac hypertrophy per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrukhova, Olena, Slavic, Svetlana, Odörfer, Kathrin I, Erben, Reinhold G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973700/ https://www.ncbi.nlm.nih.gov/pubmed/25858796 http://dx.doi.org/10.1002/jbmr.2527

Ejemplares similares

Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice
por: Ford, Kristopher, et al.
Publicado: (2018)

The bone is the major source of high circulating intact fibroblast growth factor-23 in acute murine polymicrobial sepsis induced by cecum ligation puncture
por: Bayer, Jessica, et al.
Publicado: (2021)

Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
por: Slavic, Svetlana, et al.
Publicado: (2017)

FGF23 regulates renal sodium handling and blood pressure
por: Andrukhova, Olena, et al.
Publicado: (2014)

Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction
por: Slavic, Svetlana, et al.
Publicado: (2018)

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice
por: Andrukhova, Olena, et al.
Publicado: (2018)

Thioredoxin 1 is upregulated in the bone and bone marrow following experimental myocardial infarction: evidence for a remote organ response
por: Godoy, José R., et al.
Publicado: (2020)

Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction
por: Odörfer, Kathrin I, et al.
Publicado: (2008)

Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
por: Radloff, Judith, et al.
Publicado: (2021)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent
por: Erben, Reinhold G.
Publicado: (2018)

Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
por: Murali, Sathish K., et al.
Publicado: (2016)

FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway
por: Andrukhova, Olena, et al.
Publicado: (2012)

Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo
por: Anour, René, et al.
Publicado: (2012)

Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells
por: Streicher, Carmen, et al.
Publicado: (2017)

FGF23 promotes renal calcium reabsorption through the TRPV5 channel
por: Andrukhova, Olena, et al.
Publicado: (2014)

Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction
por: Cornelissen, Anne, et al.
Publicado: (2022)

Marker tolerant, immunocompetent animals as a new tool for regenerative medicine and long-term cell tracking
por: Odörfer, Kathrin I, et al.
Publicado: (2007)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry
por: Schmitz, Timo, et al.
Publicado: (2023)

FGF23 and Vitamin D Metabolism
por: Latic, Nejla, et al.
Publicado: (2021)

Editorial: Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
por: Erben, Reinhold G.
Publicado: (2019)

Hematopoietic bone marrow cells participate in endothelial, but not epithelial or mesenchymal cell renewal in adult rats
por: Odörfer, Kathrin I, et al.
Publicado: (2011)

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019)

Genome-wide association study for circulating fibroblast growth factor 21 and 23
por: Chuang, Gwo-Tsann, et al.
Publicado: (2020)

Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
por: Freundlich, Michael, et al.
Publicado: (2020)

Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
por: Sugiura, Hidekazu, et al.
Publicado: (2018)

Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma
por: Jacobs, Elizabeth, et al.
Publicado: (2011)

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019)

Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
por: Latic, Nejla, et al.
Publicado: (2022)

A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation
por: Glosse, Philipp, et al.
Publicado: (2018)

Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
por: Xiao, Yunjun, et al.
Publicado: (2013)

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction
por: Venugopal, Harikrishnan, et al.
Publicado: (2022)

Epigenetic Upregulation of Endogenous VEGF-A Reduces Myocardial Infarct Size in Mice
por: Turunen, Mikko P., et al.
Publicado: (2014)

Serum Level of Fibroblast Growth Factor 21 Is Independently Associated with Acute Myocardial Infarction
por: Zhang, Wenduo, et al.
Publicado: (2015)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
por: Fernández-Real, José Manuel, et al.
Publicado: (2013)

Circulating Fibroblast Growth Factor-23 is Associated with Cardiovascular Prognosis and Graft Function in Renal Transplant Recipients
por: Algul Durak, Beyza, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nqvpv0anod1krghm7em74m67q4